.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 5,998,427

« Back to Dashboard

Summary for Patent: 5,998,427

Title: Androstenones
Abstract:The present invention relates to compounds of formula (I), wherein carbons 1 and 2 are joined by either a single or a double bond; R.sup.1 is hydrogen or methyl; R.sup.2 is hydrogen or methyl; R.sup.3 is (B) wherein X, R.sup.6, R.sup.7 and R.sup.8 are various groups, and pharmaceutically acceptable solvates thereof and their use in the treatment of androgen responsive and mediated diseases. ##STR1##
Inventor(s): Batchelor; Kenneth William (Durham, NC), Frye; Stephen Vernon (Durham, NC)
Assignee: Glaxo Wellcome Inc. (Research Triangle Park, NC)
Application Number:09/078,468
Patent Claim Types:
see list of patent claims
Compound; Composition; Formulation; Process; Use;
Patent Metrics:
Source: PatentQuant.com
Field: Not categorized
Back Citations: 38th percentile
Forward Citations: 1st percentile
Patent PDF download available with subscription

No matches for this query

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc